DNA Stock Overview
Engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Dna Group (T.R.) Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪0.89 |
| 52 Week High | ₪1.05 |
| 52 Week Low | ₪0.56 |
| Beta | 0.17 |
| 11 Month Change | 1.02% |
| 3 Month Change | 27.39% |
| 1 Year Change | 54.77% |
| 33 Year Change | -40.86% |
| 5 Year Change | 48.34% |
| Change since IPO | -96.91% |
Recent News & Updates
Dna Group (T.R.)'s (TLV:DNA) Earnings Might Not Be As Promising As They Seem
Sep 02
We Think Dna Group (T.R.) (TLV:DNA) Can Afford To Drive Business Growth
Apr 12Dna Group (T.R.) (TLV:DNA) Is In A Strong Position To Grow Its Business
Jul 07Recent updates
Dna Group (T.R.)'s (TLV:DNA) Earnings Might Not Be As Promising As They Seem
Sep 02We Think Dna Group (T.R.) (TLV:DNA) Can Afford To Drive Business Growth
Apr 12Dna Group (T.R.) (TLV:DNA) Is In A Strong Position To Grow Its Business
Jul 07We Think Dna Group (T.R.) (TLV:DNA) Can Easily Afford To Drive Business Growth
Jan 24We're Not Worried About D.N.A Biomedical Solutions' (TLV:DNA) Cash Burn
Oct 07Shareholder Returns
| DNA | IL Electronic | IL Market | |
|---|---|---|---|
| 7D | 18.1% | 1.5% | 0.3% |
| 1Y | 54.8% | 25.6% | 23.0% |
Return vs Industry: DNA exceeded the IL Electronic industry which returned 25.6% over the past year.
Return vs Market: DNA exceeded the IL Market which returned 23% over the past year.
Price Volatility
| DNA volatility | |
|---|---|
| DNA Average Weekly Movement | 9.6% |
| Electronic Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in IL Market | 7.3% |
| 10% least volatile stocks in IL Market | 2.9% |
Stable Share Price: DNA's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: DNA's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Ori Altschuler | n/a |
Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places.
Dna Group (T.R.) Ltd Fundamentals Summary
| DNA fundamental statistics | |
|---|---|
| Market cap | ₪109.99m |
| Earnings (TTM) | ₪15.05m |
| Revenue (TTM) | ₪306.00k |
7.3x
P/E Ratio359.4x
P/S RatioIs DNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DNA income statement (TTM) | |
|---|---|
| Revenue | ₪306.00k |
| Cost of Revenue | ₪0 |
| Gross Profit | ₪306.00k |
| Other Expenses | -₪14.74m |
| Earnings | ₪15.05m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 100.00% |
| Net Profit Margin | 4,918.63% |
| Debt/Equity Ratio | 0% |
How did DNA perform over the long term?
See historical performance and comparison